Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix

Clinical trial NCT00191100 · COMPLETED

Trial details

NCT number: NCT00191100
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer of Cervix

Start date: 2002-05-01
Primary completion: 2008-04-01
Enrollment: 515

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.